Remifentanil and etomidate for laryngeal mask airway insertion


Uzun S. , Goezacan A., Canbay O. , Oezgen S.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, cilt.35, sa.6, ss.878-885, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 35 Konu: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1177/147323000703500616
  • Dergi Adı: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
  • Sayfa Sayıları: ss.878-885

Özet

Etomidate does not depress the upper airway reflexes, making it difficult to insert a laryngeal mask airway (LMA) when using it for anaesthesia. This study investigated the effect of adding remifentanil to etomidate for LMA insertion. Fifty adult patients, undergoing cystoscopy, were randomized to two groups. The propofol-remifentanil group (n = 25) received propofol anaesthesia induction (2.5 mg/kg) and a remifentanil bolus of 0.5 mu g/kg, followed by a 2-min remifentanil infusion of 0.005 mu g/kg per min. The etomidate-remifentanil group (n = 25) received etomidate anaesthesia induction (0.3 mg/kg) and remifentanil as described. The LMA was inserted by a blinded anaesthetist who assessed a number of parameters. Only 13 LMAs were inserted at the first attempt in the etomidate-remifentanil group compared with 23 in the propofol-remifentanil group. Gagging, chest rigidity and myoclonus occurred significantly more frequently in the etomidate-remifentanil group. We conclude that the addition of remifentanil to etomidate anaesthesia induction does not improve LMA insertion.